Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
BMC Pregnancy Childbirth ; 24(1): 112, 2024 Feb 06.
Artículo en Inglés | MEDLINE | ID: mdl-38321392

RESUMEN

BACKGROUND: In many countries, abortions at 20 weeks and over for indications other than fetal or maternal medicine are difficult to access due to legal restrictions and limited availability of services. The Abortion and Contraception Service at the Royal Women's Hospital in Victoria, Australia is the only service in the state that provides this service. The views and experiences of these abortion providers can give insight into the experiences of staff and women and the abortion system accessibility. The aim of this study was to examine health providers' perceptions and experiences of providing abortion care at 20 weeks and over for indications other than fetal or maternal medicine, as well as enablers and barriers to this care and how quality of care could be improved in one hospital in Victoria, Australia. METHODS: A qualitative study was conducted at the Abortion and Contraception Service at the Royal Women's Hospital. Participants were recruited by convenience and purposive sampling. Semi-structured interviews were conducted one-on-one with participants either online or in-person. A reflexive thematic analysis was performed. RESULTS: In total, 17 healthcare providers from medicine, nursing, midwifery, social work and Aboriginal clinical health backgrounds participated in the study. Ultimately, three themes were identified: 'Being committed to quality care: taking a holistic approach', 'Surmounting challenges: being an abortion provider is difficult', and 'Meeting external roadblocks: deficiencies in the wider healthcare system'. Participants felt well-supported by their team to provide person-centred and holistic care, while facing the emotional and ethical challenges of their role. The limited abortion workforce capacity in the wider healthcare system was perceived to compromise equitable access to care. CONCLUSIONS: Providers of abortion at 20 weeks and over for non-medicalised indications encounter systemic enablers and barriers to delivering care at personal, service delivery and healthcare levels. There is an urgent need for supportive policies and frameworks to strengthen and support the abortion provider workforce and expand provision of affordable, acceptable and accessible abortions at 20 weeks and over in Victoria and in Australia more broadly.


Asunto(s)
Aborto Inducido , Actitud del Personal de Salud , Embarazo , Femenino , Humanos , Victoria , Aborto Inducido/psicología , Anticoncepción , Personal de Salud/psicología , Investigación Cualitativa , Accesibilidad a los Servicios de Salud
2.
Brain Inj ; 22(1): 103-6, 2008 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-18183514

RESUMEN

BACKGROUND: Case reports of the use of zolpidem in Permanent Vegetative States (PVS) have led to interest by the media and court judgements defining treatment with such drugs. It is uncertain whether this paradoxical effect of zolpidem in raising consciousness may be evident in other low awareness states such as Minimally Conscious State (MCS). CASE STUDY: This study treated a 44 year old male with MCS some 4 years after his traumatic brain injury with zolpidem for 1 week on and 1 week off treatment. Assessment with a number of tests by blinded therapists showed that his scores were no better on zolpidem and in some cases were worse on treatment. CONCLUSIONS: Ideally a series of individuals is required to assess the effect of zolpidem, but in the light of positive spin stories in the media, negative case reports should also be highlighted. It is imperative that medical treatment in all instances and certainly in low awareness states and end of life decisions is always based on firm evidence.


Asunto(s)
Lesiones Encefálicas/tratamiento farmacológico , Neurotransmisores/uso terapéutico , Estado Vegetativo Persistente/tratamiento farmacológico , Piridinas/administración & dosificación , Adulto , Lesiones Encefálicas/complicaciones , Evaluación de Medicamentos , Humanos , Masculino , Variaciones Dependientes del Observador , Estado Vegetativo Persistente/etiología , Resultado del Tratamiento , Zolpidem
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...